IRONWOOD PHARMACEUTICALS INC 4

Ronald Silver (PFO & PAO of Ironwood Pharmaceuticals, Inc.) sold 127,890 shares of Class A Common Stock at a weighted average price of about $4.52 on July 7, 2026 under a Rule 10b5-1 plan.

On July 7, 2026, Ronald Silver, who serves as Principal Financial Officer and Principal Accounting Officer (PFO & PAO) of Ironwood Pharmaceuticals, Inc., sold 127,890 shares of the company’s Class A Common Stock pursuant to a pre-arranged Rule 10b5-1 trading plan. The shares were sold at a weighted average price of approximately $4.52 per share, within an execution range of $4.50 to $4.57, for an estimated aggregate value of about $578,000. Following this transaction, Silver directly owns 313,680 shares of Ironwood Pharmaceuticals, representing a continuing material equity stake whose current market value is approximately $1.42 million based on the same price context.

Filing Facts

CIK

1446847

Ticker

IRWD

Form

4

Source Type

fda

Accession

0001193125-26-299749

Alert Tier

6